(Q64376577)

1

0 references

Fuminori Sakurai

2

0 references

Shin-ichiro Nakamura

3

0 references

Emi Kouyama

4

0 references

Kenji Kawabata

5

0 references

Masuo Kondoh

6

0 references

Kiyohito Yagi

Phase I study of adenoviral delivery of the HSV-tk gene and ganciclovir administration in patients with current malignant brain tumors.

7

0 references

language of work or name

English

0 references

publication date

October 2008

0 references

published in

Molecular Therapy

0 references

volume

16

0 references

issue

10

0 references

page(s)

1719-26

0 references

cites work

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.159

7 January 2021

Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells.

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.159

7 January 2021

Safety of intrapleurally administered recombinant adenovirus carrying herpes simplex thymidine kinase DNA followed by ganciclovir therapy in nonhuman primates

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.159

7 January 2021

Long-term follow-up of patients with malignant pleural mesothelioma receiving high-dose adenovirus herpes simplex thymidine kinase/ganciclovir suicide gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.159

7 January 2021

Adenovirus-mediated herpes simplex virus thymidine kinase/ganciclovir gene therapy in patients with localized malignancy: results of a phase I clinical trial in malignant mesothelioma.

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.159

7 January 2021

Suicide gene therapy with adenoviral delivery of HSV-tK gene for patients with local recurrence of prostate cancer after hormonal therapy

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.159

7 January 2021

Adenoviral vectors for gene transfer

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.159

7 January 2021

Targeted adenovirus vectors

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.159

7 January 2021

Tumor cell-specific transgene expression prevents liver toxicity of the adeno-HSVtk/GCV approach

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.159

7 January 2021

Enhanced antitumor effect and reduced vector dissemination with fiber-modified adenovirus vectors expressing herpes simplex virus thymidine kinase

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.159

7 January 2021

Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.159

7 January 2021

MicroRNAs and immunity: tiny players in a big field

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.159

7 January 2021

The evolution of gene regulation by transcription factors and microRNAs

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.159

7 January 2021

Illuminating the silence: understanding the structure and function of small RNAs

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.159

7 January 2021

Endogenous microRNA can be broadly exploited to regulate transgene expression according to tissue, lineage and differentiation state

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.159

7 January 2021

Endogenous microRNA regulation suppresses transgene expression in hematopoietic lineages and enables stable gene transfer

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.159

7 January 2021

miR-122, a mammalian liver-specific microRNA, is processed from hcr mRNA and may downregulate the high affinity cationic amino acid transporter CAT-1.

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.159

7 January 2021

Identification of tissue-specific microRNAs from mouse

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.159

7 January 2021

A mammalian microRNA expression atlas based on small RNA library sequencing

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.159

7 January 2021

siRNAs can function as miRNAs

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.159

7 January 2021

TERT promoter-driven adenovirus vector for cancer gene therapy via systemic injection

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.159

7 January 2021

A tandemly repeated thyroglobulin core promoter has potential to enhance efficacy for tissue-specific gene therapy for thyroid carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.159

7 January 2021

Cellular promoters incorporated into the adenovirus genome: effects of viral regulatory elements on transcription rates and cell specificity of albumin and beta-globin promoters

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.159

7 January 2021

Adenovirus as an expression vector in muscle cells in vivo

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.159

7 January 2021

Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.159

7 January 2021

MicroRNA signatures in human ovarian cancer

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.159

7 January 2021

In situ gene therapy for adenocarcinoma of the prostate: a phase I clinical trial.

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.159

7 January 2021

Adenoviral transfection of hepatocytes with the thioredoxin gene confers protection against apoptosis and necrosis

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.159

7 January 2021

A simple method for constructing E1- and E1/E4-deleted recombinant adenoviral vectors

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.159

7 January 2021

A simplified system for constructing recombinant adenoviral vectors containing heterologous peptides in the HI loop of their fiber knob

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.159

7 January 2021

In vitro ligation-based cloning of foreign DNAs into the E3 and E1 deletion regions for generation of recombinant adenovirus vectors

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.159

7 January 2021

Antibody-targeted cell fusion

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.159

7 January 2021

In vivo gene transfer via intravenous administration of cationic lipid-protamine-DNA (LPD) complexes

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.159

7 January 2021

Modified adenoviral vectors ablated for coxsackievirus-adenovirus receptor, alphav integrin, and heparan sulfate binding reduce in vivo tissue transduction and toxicity.

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.159

7 January 2021